vimarsana.com
Home
Live Updates
Bridge Biotherapeutics Enters into an Exclusive License Agre
Bridge Biotherapeutics Enters into an Exclusive License Agre
Bridge Biotherapeutics Enters into an Exclusive License Agreement with Shaperon to Strengthen Its IPF Franchise
/PRNewswire/ -- Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotechnology company focused on developing novel drugs for fibrosis,...
Related Keywords
China ,
Seongnam ,
Kyonggi Do ,
South Korea ,
South Korean ,
Republic Of Korea ,
Myung Sea Lee ,
James Lee ,
Seung Yong Seong ,
Biotherapeutics Inc ,
Bridge Biotherapeutics Inc ,
Bridge Biotherapeutics ,
Nc ,